Renalys Pharma
Latest round
- Series A
Last raised
- Jul 2024
Total raised
- $38M
Investors
- 6
About Renalys Pharma
Founded in 2024 and based in Tokyo, Japan, Renalys Pharma, Inc. operates as a biopharmaceutical company that develops drugs for end-stage renal diseases. The company was founded by its CEO, BT Slingsby, and CFO, Takeshi Takahashi. In January 2024, Catalys Pacific and SR One formed Renalys Pharma, Inc. Renalys Pharma offers a clinical-stage biotechnology platform that develops drugs for patients with renal diseases in Asian countries. The firm develops treatments for chronic kidney disease (CKD) and end-stage renal disease (ESRD) in Japan and Asia. The company’s product line includes sparsentan, an oral dual endothelin angiotensin receptor antagonist (DEARA), which is a non-immunosuppressive therapeutic that develops drugs for IgA nephropathy patients.
Who invested in Renalys Pharma
6 investors across 1 round
See all investors in Renalys Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 18, 2024
Amount
$38M
Investors
Questions about Renalys Pharma
Who invested in Renalys Pharma?
Renalys Pharma has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Renalys Pharma raised?
Renalys Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Renalys Pharma last raise money?
Renalys Pharma's most recent round on record is a Series A, in Jul 2024.
What does Renalys Pharma do?
Founded in 2024 and based in Tokyo, Japan, Renalys Pharma, Inc.
Where is Renalys Pharma headquartered?
Renalys Pharma is headquartered in Chuo-ku, Japan.
Which VCs invest in companies like Renalys Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Renalys Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Renalys Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.